Advanced search
Publication Cover
Current Eye Research Volume 31, 2006 - Issue 2
Submit an article Journal homepage
216
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of Ocular Angiogenesis by Diced Small Interfering RNAs (siRNAs) Specific to Vascular Endothelial Growth Factor (VEGF)

Masatoshi Murata Mitake Eye Clinic, Morioka, Japan; Department of Biochemistry, School of Medicine, Iwate Medical University, Morioka, Japan
,
Takako Takanami Department of Biochemistry, School of Medicine, Iwate Medical University, Morioka, Japan
,
Shinji Shimizu Department of Biochemistry, School of Medicine, Iwate Medical University, Morioka, Japan
,
Yosiko Kubota Department of Biochemistry, School of Medicine, Iwate Medical University, Morioka, Japan
,
Saburo Horiuchi Department of Biochemistry, School of Medicine, Iwate Medical University, Morioka, Japan
,
Wataru Habano DNA Laboratory, School of Medicine, Iwate Medical University, Morioka, Japan
,
Jian-xing Ma Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA
&
Sanai Sato Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA
 show all
Pages 171-180 | Received 01 Mar 2005, Accepted 04 Sep 2005, Published online: 02 Jul 2009

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lei Zuo, Ying Fan, Feng Wang, Qing Gu & Xun Xu. (2010) A SiRNA Targeting Vascular Endothelial Growth Factor-A Inhibiting Experimental Corneal Neovascularization. Current Eye Research 35:5, pages 375-384.
Read now
Ting Wang & Weiyun Shi. (2009) Expression of Fibroblast Activation Proteins in Corneal Stromal Neovascularization. Current Eye Research 34:2, pages 112-117.
Read now
Liang Dan, Yan Shi-long, Lin Miao-li, Li Yong-ping, Ma Hong-jie, Zhang Ying & Wang Xiang-gui. (2008) Inhibitory Effect of Oral Doxycycline on Neovascularization in a Rat Corneal Alkali Burn Model of Angiogenesis. Current Eye Research 33:8, pages 653-660.
Read now

Articles from other publishers (34)

Jonathan Tersur Orasugh, Dipankar Chattopadhyay, Suprakas Sinha Ray & Anjan Adhikari. 2024. Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery. Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery 345 360 .
Satheesh Kumar, Lewis E. Fry, Jiang-Hui Wang, Keith R. Martin, Alex W. Hewitt, Fred K. Chen & Guei-Sheung Liu. (2023) RNA-targeting strategies as a platform for ocular gene therapy. Progress in Retinal and Eye Research 92, pages 101110.
Crossref
Nadim S. Azar, Matias Soifer & Victor L. Perez. 2023. Modern Keratoplasty. Modern Keratoplasty 59 67 .
Munir Ahmed, Muhammad Umar Khayam Sahibzada, Hafiz Majid Rasheed, Taous Khan, Fazli Wahid, Umar Farooq, Ameer Khusro, Jalal Uddin, Sher Afzal, Ajmal Khan & Ahmed Al-Harrasi. (2022) Inhibition of Inflammation Associated Corneal Neovascularization by Dalbergia sissoo and Catharanthus roseus Leaf Extracts in an Animal Model. South African Journal of Botany 151, pages 379-386.
Crossref
Shibani Supe, Archana Upadhya & Kavita Singh. (2021) Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review. Experimental Eye Research 202, pages 108329.
Crossref
Jingwen Yu, Chengchao Chu, Yiming Wu, Gang Liu & Wei Li. (2021) The phototherapy toward corneal neovascularization elimination: An efficient, selective and safe strategy. Chinese Chemical Letters 32:1, pages 99-101.
Crossref
Olga Osipova, Vladimir Sharoyko, Natalia Zashikhina, Natalya Zakharova, Tatiana Tennikova, Arto Urtti & Evgenia Korzhikova-Vlakh. (2020) Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells. Pharmaceutics 12:1, pages 39.
Crossref
Jinho Park, Joonyoung Park, Yihua Pei, Jun Xu & Yoon Yeo. (2016) Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Advanced Drug Delivery Reviews 104, pages 93-109.
Crossref
AI-HUA LIU, JING SUN, YI SHI, GUO-LING SUN & HONG ZHANG. (2015) Effect of shRNA-mediated knockdown of vascular endothelial growth factor on the proliferation of choroid-retinal endothelial cells under hypoxic conditions. Experimental and Therapeutic Medicine 10:3, pages 1019-1024.
Crossref
Hyun Beom Song, Kang Ju Lee, Il Ho Seo, Ji Yong Lee, Sang-Mok Lee, Jin Hyoung Kim, Jeong Hun Kim & WonHyoung Ryu. (2015) Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery. Journal of Controlled Release 209, pages 272-279.
Crossref
Jagat R. Kanwar, Jayanth Suryanarayanan Shankaranarayanan, Sneha Gurudevan & Rupinder K. Kanwar. (2014) Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases. Drug Discovery Today 19:9, pages 1309-1321.
Crossref
Tomás Rojas, Cristian Cumsille, Rodrigo Castillo, Daniel García, Álvaro Henríquez, Rodrigo Lacroix & Javier Corvalan. (2014) Uso de terapia antifactor de crecimiento vascular endotelial en patología corneal. Revista Mexicana de Oftalmología 88:3, pages 113-119.
Crossref
Xiangjie An, Guangfen Xu, Liu Yang, Yuejue Wang, Yan Li, Uwesu O. Mchepange, Guanxin Shen, Yating Tu & Juan Tao. (2013) Expression of hypoxia‐inducible factor‐1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features. The Journal of Dermatology 41:1, pages 76-83.
Crossref
Andrey Turchinovich, Georg Zoidl & Rolf Dermietzel. 2013. Advanced Delivery and Therapeutic Applications of RNAi. Advanced Delivery and Therapeutic Applications of RNAi 417 437 .
Mohammad Shamsul Ola. (2013) Novel drugs and their targets in the potential treatment of diabetic retinopathy. Medical Science Monitor 19, pages 300-308.
Crossref
Jin-Hong Chang, Nitin K. Garg, Elisa Lunde, Kyu-Yeon Han, Sandeep Jain & Dimitri T. Azar. (2012) Corneal Neovascularization: An Anti-VEGF Therapy Review. Survey of Ophthalmology 57:5, pages 415-429.
Crossref
K. V. Glebova, A. V. Marakhonov, A. V. Baranova & M. Yu. Skoblov. (2012) Nonviral delivery systems for small interfering RNAs. Molecular Biology 46:3, pages 349-361.
Crossref
Garrett R Rettig & Mark A Behlke. (2012) Progress Toward In Vivo Use of siRNAs-II. Molecular Therapy 20:3, pages 483-512.
Crossref
F. Beilvert, M. Mével, Benoît Chatin & B. Pitard. (2012) Local siRNA delivery by non-viral vectors. Journal of Drug Delivery Science and Technology 22:1, pages 17-27.
Crossref
Deepak Gupta & Chris Illingworth. (2011) Treatments for Corneal Neovascularization: A Review. Cornea 30:8, pages 927-938.
Crossref
Michael Monaghan & Abhay Pandit. (2011) RNA interference therapy via functionalized scaffolds. Advanced Drug Delivery Reviews 63:4-5, pages 197-208.
Crossref
Sherry Y. Wu & Nigel A. J. McMillan. (2009) Lipidic Systems for In Vivo siRNA Delivery. The AAPS Journal 11:4, pages 639-652.
Crossref
Ripal Gaudana, J. Jwala, Sai H. S. Boddu & Ashim K. Mitra. (2008) Recent Perspectives in Ocular Drug Delivery. Pharmaceutical Research 26:5.
Crossref
G Lombardi, A Calistri, M Curtarello, G L Giudice, S Piermarocchi, G Prosdocimo, G Palù & C Parolin. (2009) HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells. British Journal of Ophthalmology 93:2, pages 244-248.
Crossref
Maryam Keshavarz, Ali Mostafaie, Kamran Mansouri, Yadollah Shakiba & Hamid Reza Mohammadi Motlagh. (2009) Inhibition of Corneal Neovascularization with Propolis Extract. Archives of Medical Research 40:1, pages 59-61.
Crossref
Jian Jiang, Xiao‐Bo Xia, Hui‐Zhuo Xu, Yu Xiong, Wei‐Tao Song, Si‐Qi Xiong & Yan Li. (2008) Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF‐1α and VEGF. Journal of Cellular Physiology 218:1, pages 66-74.
Crossref
Elias Fattal & Amélie Bochot. (2008) State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. International Journal of Pharmaceutics 364:2, pages 237-248.
Crossref
Wei Zhao, Yu-Sheng Wang, Yan-Nian Hui, Jie Zhu, Peng Zhang, Xia Li & Guo-Rui Dou. (2008) Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1α with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system. Graefe's Archive for Clinical and Experimental Ophthalmology 246:10, pages 1413-1422.
Crossref
Francesca Seta, Kiran Patil, Lars Bellner, Alexandre Mezentsev, Rowena Kemp, Michael W. Dunn & Michal Laniado Schwartzman. (2007) Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins & Other Lipid Mediators 84:3-4, pages 116-127.
Crossref
Farzin Forooghian & Bikul Das. (2007) Anti-Angiogenic Effects of Ribonucleic Acid Interference Targeting Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1α. American Journal of Ophthalmology 144:5, pages 761-768.
Crossref
Yadollah Shakiba & Ali Mostafaie. (2007) Inhibition of Corneal Neovascularization with a Nutrient Mixture Containing Lysine, Proline, Ascorbic Acid, and Green Tea Extract. Archives of Medical Research 38:7, pages 789-791.
Crossref
Hamid Hosseini & Mahmood Nejabat. (2007) A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Medical Hypotheses 68:4, pages 799-801.
Crossref
Tiejun Li, Jianning Song, Kai Kang, Zanlan Hu, Tongchuan He, Bingqiang Zhang & Caiquan Zhang. (2006) RNA interference-mediated gene silencing of vascular endothelial growth factor. Chinese Journal of Clinical Oncology 3:6, pages 408-412.
Crossref
Elias Fattal & Amélie Bochot. (2006) Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Advanced Drug Delivery Reviews 58:11, pages 1203-1223.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.